PBE vs. PBPH
PBE (Invesco Dynamic Biotechnology & Genome ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - PBE tracks the Dynamic Biotech & Genome Intellidex Index (AMEX) while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. A 0.76 correlation means they provide meaningful diversification when combined. PBE charges 0.59%/yr vs 0.13%/yr for PBPH.
Performance
PBE vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 0.58% return, which is significantly higher than PBPH's -1.13% return.
PBE
- 1D
- 2.04%
- 1M
- 2.68%
- YTD
- 0.58%
- 6M
- 1.15%
- 1Y
- 30.26%
- 3Y*
- 10.44%
- 5Y*
- 3.06%
- 10Y*
- 7.55%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PBE vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.58% | -0.32% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between PBE and PBPH is 0.76, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.76 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. PBPH — Risk / Return Rank
PBE
PBPH
PBE vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.28 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.59 | — | — |
| Martin ratioReturn relative to average drawdown | 7.27 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PBE | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.63 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | -0.04 | +0.37 |
Drawdowns
PBE vs. PBPH - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for PBE and PBPH.
Loading charts...
Drawdown Indicators
| PBE | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -11.10% | -34.59% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | — | — |
Current DrawdownCurrent decline from peak | -3.62% | -8.69% | +5.07% |
Average DrawdownAverage peak-to-trough decline | -16.24% | -4.23% | -12.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | — | — |
Volatility
PBE vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| PBE | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.63% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 13.27% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.71% | 16.78% | +1.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.54% | 16.78% | +5.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.92% | 16.78% | +8.14% |
PBE vs. PBPH - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
PBE vs. PBPH - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.05%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.05% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PBE and PBPH have a correlation of 0.76, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.59% for PBE.
PBE has the higher dividend yield at 1.05%, compared with 0.09% for PBPH.
PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Invesco and Portfolio Building Block. Their fees differ too: 0.59% for PBE and 0.13% for PBPH.
Find the right allocation for PBE and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer